首页 | 本学科首页   官方微博 | 高级检索  
     

抗抑郁药治疗胆囊切除术后慢性疼痛的临床研究
引用本文:陈玉龙,尚杰,王霞,陈长阁,刘华,许春进. 抗抑郁药治疗胆囊切除术后慢性疼痛的临床研究[J]. 胃肠病学和肝病学杂志, 2004, 13(4): 409-410
作者姓名:陈玉龙  尚杰  王霞  陈长阁  刘华  许春进
作者单位:450052,郑州,郑州大学第一附属医院消化内科
摘    要:目的 评价路优泰治疗胆囊切除患者慢性疼痛的疗效。方法 将 64例慢性疼痛的胆囊切除患者随机分为抗抑郁剂路优泰组 3 2例和安慰剂组 3 2例 ,治疗 6周 ,应用慢性疼痛评价标准及汉密尔顿抑郁量表 (HAMD ;17项 )于治疗前及治疗第 1、2、4、6周末进行疗效评定。结果 路优泰组的 3 2例中有效率分别为 87.5 %和 84.4% ,而安慰剂组中的有效率分别为 2 8.1%和 3 4.4% ,两组比较差异有显著性 (P <0 .0 1)。结论 路优泰是治疗慢性疼痛的有效药物之一

关 键 词:抗抑郁药 治疗 胆囊切除术 慢性疼痛 临床研究
修稿时间:2004-07-01

A clinical study of neurostan on chronic pain after cholecystectomy
CHEN Yulong,SHANG Jie,WANG Xia,et al. A clinical study of neurostan on chronic pain after cholecystectomy[J]. Chinese Journal of Gastroenterology and Hepatology, 2004, 13(4): 409-410
Authors:CHEN Yulong  SHANG Jie  WANG Xia  et al
Affiliation:CHEN Yulong,SHANG Jie,WANG Xia,et al Department of Degestive Medcine,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China
Abstract:Objective To evaluate the efficacy of neurostan in the treatment of patients with chronic pain after cholecystectomy.Methods Sixty four patients were randomly divided into two groups as neurostan group (32 cases) and placebo group (32 cases) and treated for 6 weeks.The criteria of the clinical therapeutic efficacy on chronic pain and Hamilton Depression Scale(HAMD;17 items) were used to assess the therapeutic effect before treatment and 1,2,4,6 weeks after treatment.Results The response rate on chronic pain and antidepression were 87.5%,84.4% in neurostan group and 28.1%,34.4% in placebo group respectively.There was a significant difference between the two groups( P <0.05).Conclusion Neurostan is one of the effective agents in the treatment of chronic pain.
Keywords:Neurostan  Chronic pain  Depression
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号